Terms: = Leukemia AND uPA AND Diagnosis
9 results:
1. Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma.
Bønløkke ST; Fenger-Eriksen C; Ommen HB; Hvas AM
Blood Adv; 2023 Nov; 7(22):7056-7066. PubMed ID: 37756519
[TBL] [Abstract] [Full Text] [Related]
2. High expression of urokinase plasminogen activator receptor (upa-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
[TBL] [Abstract] [Full Text] [Related]
3. Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: a possible relation to disease invasion.
Aref S; El-Sherbiny M; Mabed M; Menessy A; El-Refaei M
Hematology; 2003 Dec; 8(6):385-91. PubMed ID: 14668033
[TBL] [Abstract] [Full Text] [Related]
4. [Clinical significance of hemostatic molecular markers in acute leukemia].
Wu F; Wang X; Qu B; Huang X; Wang H
Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):141-4. PubMed ID: 11877066
[TBL] [Abstract] [Full Text] [Related]
5. [A study of tissue factor expression and hemostatic molecular markers in patients with acute promyelocytic leukemia].
Wu F; Wang X; Zhao W; Wang H; Shen Z
Zhonghua Nei Ke Za Zhi; 2001 Jan; 40(1):36-9. PubMed ID: 11798557
[TBL] [Abstract] [Full Text] [Related]
6. Effects of all-trans-retinoic acid and arsenic trioxide on the hemostatic disturbance associated with acute promyelocytic leukemia.
Zhao W; Wang H; Wang X; Wu F; Guo W; Qu B; Shen Z; Wang Z
Thromb Res; 2001 May; 102(3):197-204. PubMed ID: 11369412
[TBL] [Abstract] [Full Text] [Related]
7. Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy.
Mustjoki S; Sidenius N; Sier CF; Blasi F; Elonen E; Alitalo R; Vaheri A
Cancer Res; 2000 Dec; 60(24):7126-32. PubMed ID: 11156421
[TBL] [Abstract] [Full Text] [Related]
8. Philadelphia positive acute lymphoblastic leukaemia (ALL): clinico-haematologic characteristics, molecular analyses and 3-year follow up--a single institution study.
Vellupillai M; Tan LT; Lau LC; Fook-Chong SM; Lim LC
Ann Acad Med Singap; 2000 Mar; 29(2):159-63. PubMed ID: 10895331
[TBL] [Abstract] [Full Text] [Related]
9. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis.
Knapp W; Strobl H; Majdic O
Cytometry; 1994 Dec; 18(4):187-98. PubMed ID: 7534675
[TBL] [Abstract] [Full Text] [Related]